Strides Pharma Science Ltd.

₹971.15

7.5 (0.8%)

STAR Share Price

Pharmaceuticals & Biotechnology

As on April 2, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 8,934 Cr

P/E Ratio2.49

Dividend Yield0.04 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	948.4	Bullish
10-DMA	927.15	Bullish
20-DMA	902.63	Bullish
50-DMA	874.41	Bullish
100-DMA	895.09	Bullish
200-DMA	880.49	Bullish

Historical Performance

1 Year

45%

3 Years

239.1%

5 Years

14.2%

10 Years

-8.6%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	45,653	38,901	36,884	30,702	33,159
Total Expenditure	37,676	33,179	33,031	30,918	26,891
Other Income	638	498	1,352	1,334	594
Operating Profit	8,615	6,221	5,205	1,119	6,863
Interest	2,489	2,802	2,611	1,767	1,501
Depreciation	1,923	2,136	2,433	2,330	2,063
Profit Before Tax	4,869	-1,148	-2,862	-6,525	2,754
Consolidated Net Profit	35,935	-706	-2,026	-4,602	2,684
Adjusted EPS	390	-8	-22	-51	30

Compounded Sales Growth

10 Years:30.7

5 Years:10.7

3 Years:8.3

TTM:3.3

Compounded Profit Growth

10 Years:33.6

5 Years:150.6

3 Years:22

TTM:77.5

Stock Price CAGR

10 Years:-0.9

5 Years:2.7

3 Years:47.5

TTM:38.9

Return on Equity

10 Years:12.1

5 Years:29.9

3 Years:-22.4

last year:389.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	922	919	903	898	897
Total Reserves	24,592	20,306	21,025	22,670	26,823
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	6,016	6,214	12,103	9,657	12,644
Other Current Liabilities	3,074	3,416	5,279	6,972	4,210
Short Term Borrowings	11,364	15,742	13,308	14,965	10,238
Total Liabilities	57,796	55,724	63,734	67,607	68,168
Capital Work in Progress	996	799	483	562	2,276
Long Term Loans & Advances	1,402	2,561	2,172	2,106	1,878
Currents Investments	695	1,058	508	---	994
Short Term Loans and Advances	1,359	1,750	1,533	1,455	1,285
Total Current Assets	30,989	29,690	31,352	33,618	28,172
Total Assets	57,796	55,724	63,734	67,607	68,168
Adjusted Book Value	277	231	243	262	309

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of 2.49, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 47.5%, indicating sustained price appreciation.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹8615 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹45653 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1389043.8

No. of Shares: 1430 (Approx)

Performance:38.9%

P/L: ₹389043.8

NIFTY Performance: -2.3%

1 day Top Gainers